The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Accord Healthcare’s Henlius-partnered Hetronifly ...

Gilead Sciences and Kymera Therapeutics have entered into a partnership worth as much as $750m to develop a molecular glue ...

The Committee for Medicinal Products for Human Use (CHMP) has recommended that the drug be authorised to treat unresectable ...

The Considered has announced the appointment of Emily Knight-Kristoffersen as its new chief creative officer.

This is the key thing you need to know about healthcare professional (HCP) engagement – the desire for authentic human ...